INDV vs QDEL: fair value comparison
Indivior Pharmaceuticals, Inc. and QuidelOrtho Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, QDEL currently sits closer to the top of our discount ranking. INDV carries the stronger quality grade.
| INDV | QDEL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $34.56 | $13.75 |
| 12-month range | $23.46–$40.25 | $12.64–$31.25 |
| Sector rank | #29 of 113 Healthcare | #28 of 113 Healthcare |
| Quality grade | C | F |
| Leverage | Low | High |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Declining |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The bottom quarter |
Full single-stock breakdowns: INDV fair value analysis · QDEL fair value analysis